Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
+1.87M
-
Total reported value, excl. options
-
$104M
-
Value change
-
+$13.4M
-
Put/Call ratio
-
1.04
-
Number of buys
-
31
-
Number of sells
-
-10
-
Price
-
$7.20
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2014
55 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2014.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 71.9M outstanding shares and own 20.14% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT CO LLP (5.12M shares), ORBIMED ADVISORS LLC (1.64M shares), DAVIS SELECTED ADVISERS (1.24M shares), FIL Ltd (1.07M shares), RENAISSANCE TECHNOLOGIES LLC (1.03M shares), Visium Asset Management, LP (1M shares), BlackRock Fund Advisors (677K shares), PICTET ASSET MANAGEMENT LTD (488K shares), JANE STREET GROUP, LLC (222K shares), and BOGLE INVESTMENT MANAGEMENT L P /DE/ (197K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.